INFLARX NV's ticker is IFRX and the CUSIP is N44821101. A total of 1 filers reported holding INFLARX NV in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,906 | +185.3% | 8,022 | +326.9% | 0.00% | – |
Q2 2023 | $8,380 | +93011.1% | 1,879 | -59.6% | 0.00% | – |
Q1 2023 | $9 | +50.0% | 4,646 | +128.0% | 0.00% | – |
Q4 2022 | $6 | -99.9% | 2,038 | -22.9% | 0.00% | – |
Q3 2022 | $7,000 | +40.0% | 2,643 | -29.8% | 0.00% | – |
Q2 2022 | $5,000 | +400.0% | 3,764 | +1529.4% | 0.00% | – |
Q4 2021 | $1,000 | -95.7% | 231 | -95.0% | 0.00% | -100.0% |
Q4 2020 | $23,000 | +155.6% | 4,590 | +135.1% | 0.00% | – |
Q3 2020 | $9,000 | -10.0% | 1,952 | -6.0% | 0.00% | – |
Q2 2020 | $10,000 | +900.0% | 2,076 | +689.4% | 0.00% | – |
Q1 2020 | $1,000 | -97.6% | 263 | -97.4% | 0.00% | -100.0% |
Q4 2019 | $41,000 | +925.0% | 10,175 | +596.4% | 0.00% | – |
Q3 2019 | $4,000 | -60.0% | 1,461 | -52.8% | 0.00% | -100.0% |
Q2 2019 | $10,000 | -68.8% | 3,098 | +262.8% | 0.00% | -50.0% |
Q1 2019 | $32,000 | +45.5% | 854 | +43.0% | 0.00% | 0.0% |
Q4 2018 | $22,000 | -83.6% | 597 | -84.7% | 0.00% | -80.0% |
Q3 2018 | $134,000 | +45.7% | 3,905 | +36.7% | 0.01% | +100.0% |
Q2 2018 | $92,000 | +26.0% | 2,857 | +13.2% | 0.01% | -16.7% |
Q1 2018 | $73,000 | +812.5% | 2,524 | +569.5% | 0.01% | +500.0% |
Q4 2017 | $8,000 | – | 377 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 1,766,038 | $56,955,000 | 17.85% |
RA Capital Management | 1,967,148 | $63,441,000 | 4.12% |
Cormorant Asset Management, LP | 1,487,265 | $47,964,000 | 3.55% |
Redmile Group, LLC | 2,027,700 | $65,393,000 | 2.22% |
EMORY UNIVERSITY | 77,554 | $2,501,000 | 1.66% |
Eventide Asset Management | 275,000 | $8,869,000 | 0.37% |
Birchview Capital, LP | 16,000 | $516,000 | 0.35% |
Artal Group S.A. | 500,000 | $16,125,000 | 0.34% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,385,659 | $76,938,000 | 0.18% |
Baker Brothers Advisors | 258,824 | $8,347,000 | 0.06% |